These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
432 related items for PubMed ID: 11149494
1. Effects of a new selective estrogen receptor modulator (MDL 103,323) on cancellous and cortical bone in ovariectomized ewes: a biochemical, histomorphometric, and densitometric study. Chavassieux P, Garnero P, Duboeuf F, Vergnaud P, Brunner-Ferber F, Delmas PD, Meunier PJ. J Bone Miner Res; 2001 Jan; 16(1):89-96. PubMed ID: 11149494 [Abstract] [Full Text] [Related]
3. Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model. Lee YS, Gupta R, Kwon JT, Cho DC, Seo YJ, Seu SY, Park EK, Han I, Kim CH, Sung JK, Kim KT. Spine J; 2018 Oct; 18(10):1877-1887. PubMed ID: 29793000 [Abstract] [Full Text] [Related]
7. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion. Shen V, Birchman R, Wu DD, Lindsay R. J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865 [Abstract] [Full Text] [Related]
8. The effects of nandrolone decanoate on bone mass and metabolism in ovariectomized rats with osteopenia. Li X, Takahashi M, Kushida K, Shimizu S, Hoshino H, Suzuki M, Inoue T. J Bone Miner Metab; 2000 Apr; 18(5):258-63. PubMed ID: 10959614 [Abstract] [Full Text] [Related]
9. The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus monkeys. Jerome CP, Power RA, Obasanjo IO, Register TC, Guidry M, Carlson CS, Weaver DS. Bone; 1997 Apr; 20(4):355-64. PubMed ID: 9108356 [Abstract] [Full Text] [Related]
11. Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized rats. Ke HZ, Crawford DT, Qi H, Pirie CM, Simmons HA, Chidsey-Frink KL, Chen HK, Jee WS, Thompson DD. Bone; 1999 Jan; 24(1):41-7. PubMed ID: 9916783 [Abstract] [Full Text] [Related]
16. Prophylactic effects of 1,24,25-trihydroxyvitamin D3 on ovariectomy-induced cancellous bone loss in the rat. Erben RG, Bante U, Birner H, Stangassinger M. Calcif Tissue Int; 1997 May; 60(5):434-40. PubMed ID: 9115161 [Abstract] [Full Text] [Related]
17. Bone loss in the ovariectomized baboon Papio ursinus: densitometry, histomorphometry and biochemistry. Mas ID, Biscardi A, Schnitzler CM, Ripamonti U. J Cell Mol Med; 2007 May; 11(4):852-67. PubMed ID: 17760845 [Abstract] [Full Text] [Related]
18. Synergistic Effects of Genistein and Zinc on Bone Metabolism and the Femoral Metaphyseal Histomorphology in the Ovariectomized Rats. Qi S. Biol Trace Elem Res; 2018 Jun; 183(2):288-295. PubMed ID: 28842860 [Abstract] [Full Text] [Related]
19. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia. Tanaka M, Mori H, Kayasuga R, Ochi Y, Kawada N, Yamada H, Kishikawa K. Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415 [Abstract] [Full Text] [Related]
20. Effects of 16 weeks of treatment with tibolone on bone mass and bone mechanical and histomorphometric indices in mature ovariectomized rats with established osteopenia on a low-calcium diet. Yoshitake K, Yokota K, Kasugai Y, Kagawa M, Sukamoto T, Nakamura T. Bone; 1999 Sep; 25(3):311-9. PubMed ID: 10495135 [Abstract] [Full Text] [Related] Page: [Next] [New Search]